Arcus Biosciences (RCUS) Shares Outstanding (Weighted Average) (2017 - 2025)
Historic Shares Outstanding (Weighted Average) for Arcus Biosciences (RCUS) over the last 7 years, with Q3 2025 value amounting to $106.5 million.
- Arcus Biosciences' Shares Outstanding (Weighted Average) rose 1652.08% to $106.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $106.5 million, marking a year-over-year increase of 1652.08%. This contributed to the annual value of $90.1 million for FY2024, which is 2175.68% up from last year.
- Arcus Biosciences' Shares Outstanding (Weighted Average) amounted to $106.5 million in Q3 2025, which was up 1652.08% from $106.1 million recorded in Q2 2025.
- In the past 5 years, Arcus Biosciences' Shares Outstanding (Weighted Average) ranged from a high of $106.5 million in Q3 2025 and a low of $69.3 million during Q4 2021
- Over the past 5 years, Arcus Biosciences' median Shares Outstanding (Weighted Average) value was $74.3 million (recorded in 2023), while the average stood at $82.6 million.
- As far as peak fluctuations go, Arcus Biosciences' Shares Outstanding (Weighted Average) soared by 2648.96% in 2021, and later skyrocketed by 194.99% in 2023.
- Arcus Biosciences' Shares Outstanding (Weighted Average) (Quarter) stood at $69.3 million in 2021, then grew by 3.9% to $72.0 million in 2022, then increased by 2.78% to $74.0 million in 2023, then increased by 21.76% to $90.1 million in 2024, then grew by 18.2% to $106.5 million in 2025.
- Its Shares Outstanding (Weighted Average) was $106.5 million in Q3 2025, compared to $106.1 million in Q2 2025 and $98.4 million in Q1 2025.